Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Psoriasis vulgaris in a chronic stable phase and with a plaque area of mild to moderate severity sufficient for six treatment fields located in up to three plaque areas
Target lesion(s) should be on the trunk or extremities (excluding palms/soles).
You may not be if
History of skin sensitivity to topical prescription or non prescription products such as creams, lotions and cosmetics
Psoriasis guttata, psoriasis punctata, psoriasis erythrodermatica, and pustular psoriasis
Treatment with any biologics within 3 months prior to Day 1 of the study and during the study
Clareo Health | Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis
